Enzon Pharmaceuticals, Inc. (ENZN)
Total Valuation
ENZN has a market cap or net worth of $24.88 million. The enterprise value is -$22.76 million.
| Market Cap | 24.88M |
| Enterprise Value | -22.76M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ENZN has 74.21 million shares outstanding. The number of shares has increased by 45.23% in one year.
| Shares Outstanding | 74.21M |
| Shares Change (YoY) | +45.23% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.71% |
| Owned by Institutions (%) | 48.58% |
| Float | 30.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 77.76 |
| PB Ratio | 5.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | 118.50 |
| Quick Ratio | 118.29 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
Financial Efficiency
Return on equity (ROE) is -42.10%, which is considered low.
| Return on Equity (ROE) | -42.10% |
| Return on Assets (ROA) | -5.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENZN has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.96% in the last 52 weeks. The beta is -0.03, so ENZN's price volatility has been lower than the market average.
| Beta (1Y) | -0.03 |
| 52-Week Price Change | -49.96% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.33 |
| Average Volume (30 Days) | 43,871 |
Short Selling Information
The latest short interest is 259,381, so 0.35% of the outstanding shares have been sold short.
| Short Interest | 259,381 |
| Short % of Shares Out | 0.35% |
| Short % of Float | 0.86% |
| Short Ratio (days to cover) | 1.71 |
Income Statement
In the last 12 months, ENZN had revenue of $320,000 and -771,000 in losses. Earnings per share was -$0.04.
| Revenue | 320,000 |
| Gross Profit | 701,000 |
| Operating Income | -469,000 |
| Pretax Income | -462,000 |
| Net Income | -469,000 |
| Net Income Common | -771,000 |
| EBITDA | -462,000 |
| EBIT | -462,000 |
| Earnings Per Share (EPS) | -$0.04 |
Balance Sheet
The company has $47.64 million in cash and no debt, giving a net cash position of $47.64 million or $0.64 per share.
| Cash & Cash Equivalents | 47.64M |
| Total Debt | 0 |
| Net Cash | 47.64M |
| Net Cash Per Share | $0.64 |
| Book Value | 4.87M |
| Book Value Per Share | 0.07 |
| Working Capital | 47.35M |
Cash Flow
| Operating Cash Flow | -501,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | -501,000 |
| FCF Per Share | n/a |
Margins
Gross margin is 219.06%, with operating and profit margins of -146.56% and -240.94%.
| Gross Margin | 219.06% |
| Operating Margin | -146.56% |
| Pretax Margin | -144.38% |
| Profit Margin | -240.94% |
| EBITDA Margin | -144.38% |
| EBIT Margin | -144.38% |
| FCF Margin | -156.56% |
Dividends & Yields
ENZN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -3.10% |
| FCF Yield | -2.01% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.23% |
| Shareholder Yield | -45.23% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Sep 29, 2017 |
| Split Type | n/a |
| Split Ratio | 1:1 |